[ORALMEDIC® for treatment of aphthous stomatitis--possible side effects with repeated applications].

Refu'at ha-peh veha-shinayim (1993) Pub Date : 2014-10-01
S Jarjoura, I Kaplan
{"title":"[ORALMEDIC® for treatment of aphthous stomatitis--possible side effects with repeated applications].","authors":"S Jarjoura,&nbsp;I Kaplan","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>ORALMEDIC® (HybenX, Epien Medical Inc., Minneapolis, MN, USA) is a relatively recent commercial agent designated for the treatment of recurrent aphthous stomatitis (RAS). It has the potential to safely and effectively reduce pain associated with RAS. We present two patients who used ORALMEDIC® to reduce pain caused by RAS lesions. Both patients developed side effects presenting as deep ulcerations with a necrotic base at the location where ORALMEDIC® has been repeatedly applied as pain did not diminish after the first application. One patient used ORALMEDIC® several times on the same lesion. However the other patient followed the manufacturer instructions when he successively used ORALMEDIC® stick twice over the same lesion. Patients were treated with systemic antibiotics and local antiseptic agents. The healing process of the ulcers was slow and has completed its course within six weeks. It is suggested that when dental surgeons recommend ORALMEDIC®, they should emphasize the importance of using this agent according to the manufacturer's instructions in order to minimize the risk for side effects.</p>","PeriodicalId":82453,"journal":{"name":"Refu'at ha-peh veha-shinayim (1993)","volume":"31 4","pages":"10-2, 59"},"PeriodicalIF":0.0000,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Refu'at ha-peh veha-shinayim (1993)","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

ORALMEDIC® (HybenX, Epien Medical Inc., Minneapolis, MN, USA) is a relatively recent commercial agent designated for the treatment of recurrent aphthous stomatitis (RAS). It has the potential to safely and effectively reduce pain associated with RAS. We present two patients who used ORALMEDIC® to reduce pain caused by RAS lesions. Both patients developed side effects presenting as deep ulcerations with a necrotic base at the location where ORALMEDIC® has been repeatedly applied as pain did not diminish after the first application. One patient used ORALMEDIC® several times on the same lesion. However the other patient followed the manufacturer instructions when he successively used ORALMEDIC® stick twice over the same lesion. Patients were treated with systemic antibiotics and local antiseptic agents. The healing process of the ulcers was slow and has completed its course within six weeks. It is suggested that when dental surgeons recommend ORALMEDIC®, they should emphasize the importance of using this agent according to the manufacturer's instructions in order to minimize the risk for side effects.

[ORALMEDIC®用于治疗口疮性口炎-重复使用可能产生的副作用]。
ORALMEDIC®(HybenX, Epien Medical Inc., Minneapolis, MN, USA)是一种相对较新的商业化药物,用于治疗复发性口疮性口炎(RAS)。它具有安全有效地减轻RAS相关疼痛的潜力。我们报告了两例使用ORALMEDIC®减轻RAS病变引起的疼痛的患者。两例患者均出现副作用,表现为ORALMEDIC®反复应用部位的深部溃疡和坏死基底,因为第一次应用后疼痛没有减轻。一名患者在同一病灶上多次使用ORALMEDIC®。然而,另一名患者按照制造商的说明,在相同的病变上连续两次使用ORALMEDIC®棒。患者给予全身抗生素和局部抗菌剂治疗。溃疡的愈合过程很慢,在六周内就结束了。建议牙科医生在推荐使用ORALMEDIC®时,应根据制造商的说明强调使用该药物的重要性,以尽量减少副作用的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书